Analisis Utilitas Biaya Annual Population-Based Screening Dibandingkan dengan Opportunistic Screening Diabetes Melitus di Indonesia Menggunakan Markov Model
Abstract
Keywords
Full Text:
PDF (Bahasa Indonesia)References
Chisholm-Burns MA, Schwinghammer TL, Wells BG, Malone PM, Kolesar J, Dipiro JT. Pharmacotherapy Principle & practice. 4th ed. McGraw-Hill Education; 2016.
International Diabetes Federation. IDF Diabetes Atlas Ninth edition [Internet]. International DIabetes Federation; 2019. Available from: www.diabetesatlas.org
Sortsø C, Komkova A, Sandbæk A, Griffin SJ, Emneus M, Lauritzen T, et al. Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia. 2018;61(6):1306–14.
Najafi B, Farzadfar F, Ghaderi H, Hadian M. Cost effectiveness of type 2 diabetes screening: A systematic review. Med J Islam Repub Iran. 2016;29(326):1–9.
Toscano CM, Zhuo X, Imai K, Duncan BB, Polanczyk CA, Zhang P, et al. Cost-effectiveness of a national population-based screening program for type 2 diabetes: The Brazil experience. Diabetol Metab Syndr. 2015;7(95):1–11.
Arifin B, van Asselt ADI, Setiawan D, Atthobari J, Postma MJ, Cao Q. Diabetes distress in Indonesian patients with type 2 diabetes: a comparison between primary and tertiary care. BMC Health Serv Res. 2019;19(773):1–11.
Hidayat B, Suastika K, Rudijanto A, Ramadani R, Ratnasari E, Chairunisa G, et al. Policy Brief: Beban Biaya Pengobatan Langsung Diabetes Mellitus Tipe 2 dan Komplikasinya di Indonesia. CHEPS dan PB-PERKENI. 2021.
Grint D, Alisjhabana B, Ugarte-gil C, Riza A, Walzl G, Pearson F, et al. Accuracy of diabetes screening methods used for people with Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa. Bull World Heal Organ. 2018;96:738–49.
Paputungan SR, Adam FM, Adam JM. Opportunistic Screening for The Detection of Newly Diagnosed Diabetes Melitus. Indones J Cardiol. 2014;34(3):154–9.
World Health Organization. Global Health Observatory data repository: Life tables by country Indonesia [Internet]. 2020. Available from: https://apps.who.int/gho/data/?theme=main&vid=60750(Diakses pada tanggal 20 Januari 2021)
Yoo H, Choo E, Lee S. Study of hospitalization and mortality in Korean diabetic patients using the diabetes complications severity index. BMC Endocr Disord. 2020;20(1):1–10.
International Diabetes Federation. IDF Diabetes Atlas Eight Edition [Internet]. International DIabetes Federation. International DIabetes Federation; 2017. Available from: www.diabetesatlas.org
Sosale A, Prasanna Kumar K, Sadikot S, Nigam A, Bajaj S, Zargar A, et al. Chronic complications in newly diagnosed patients with Type 2 diabetes mellitus in India. Indian J Endocrinol Metab. 2014;18(3):355–60.
U.K Prospective Diabetes Study Group. U.K. Prospective diabetes study 16: Overview of 6 years’ therapy of type II diabetes: A progressive disease. Diabetes Am Diabetes Assoc Inc. 1995;44(11):1249–58.
World Health Organization. Guide to cost-Effectiveness Analysis. WHO.Ganeva; 2003.
Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan RI No.52 Tahun 2016 Tentang Standar Tarif Pelayanan Kesehatan Dalam Penyelenggaraan Program Jaminan Kesehatan. Kemenkes RI. Jakarta: Kemenkes RI. Jakarta; 2016.
Baroroh F, Solikah WY, Urfiyya QA. Analisis Biaya Terapi Diabetes Melitus Tipe 2 Di Rumah Sakit Pku Muhammadiyah Bantul Yogyakarta Cost Analysis of Type 2 Diabetes Mellitus in Pku Muhammadiyah Bantul Yogyakarta Hospital. J Farm Sains dan Prakt. 2016;I(2):11–22.
Kristina SARI, Endarti DWI, Andayani TRIM, Widayanti AW. Direct and Indirect Cost of Diabetes Mellitus in Indonesia: A Prevalence Based Study with Human Capital Approach. Int J Pharm Res. 2020;13(01).
Priyadi A, Permana H, Muhtadi A, Sumiwi SA, Sinuraya RK, Suwantika AA. Cost-effectiveness analysis of type 2 diabetes mellitus (T2dm) treatment in patients with complications of kidney and peripheral vascular diseases in Indonesia. Healthc [Internet]. 2021;9(211):1–9. Available from: www.mdpi.com/journal/healthcare
Purba FD, Hunfeld JAM, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Passchier J, et al. Quality of life of the Indonesian general population: Test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF. PLoS One. 2018;13(5):1–20.
Arifin B, Idrus LR, van Asselt ADI, Purba FD, Perwitasari DA, Thobari JA, et al. Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D. Qual Life Res. 2019;28(5):1179–90.
Andayani TM, Kristina SA, Endarti D, Wahyuni ST, Rahmawati A. Health utility score in type 2 diabetes mellitus. Pharm Sci Asia. 2020;47(3):246–52.
Ipsen EØ, Madsen KS, Chi Y, Pedersen-Bjergaard U, Richter B, Metzendorf MI, et al. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in person increased at risk for the development of type 2 diabetes mellitus (Review). Cochrane Database Syst Rev. 2020;2020(11):1–3.
Paul SK, Klein K, Thorsted BL, Wolden ML, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14(1):1–10.
Cheng SW, Wang CY, Chen JH, Ko Y. Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis. Med (United States). 2018;97(31):1–7.
Robinson LA, Hammitt JK, Chang AY, Resch S. Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds. Health Policy Plan. 2017;32(1):141–5.
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of health Care programmes. Fourth. New York: Oxford University Press; 2015.
Ben ÂJ, Neyeloff JL, de Souza CF, Rosses APO, de Araujo AL, Szortika A, et al. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System. Appl Health Econ Health Policy [Internet]. 2020;18(1):57–68. Available from: https://doi.org/10.1007/s40258-019-00528-w
Suwantika AA, Priyadi A, Muhtadi A, Sumiwi SA. An economic evaluation of diabetes mellitus management in South East Asia. J Adv Pharm Educ Res. 2019;9(2):53–74.
Srisubat A, Sriratanaban J, Ngamkiatphaisan S, Tungsanga K. Cost-effectiveness of annual microalbuminuria screening in Thai diabetics. Asian Biomed. 2014;8(3):371–9.
Refbacks
- There are currently no refbacks.
Indonesian Journal of Clinical Pharmacy is indexed by
